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Abstract
Background: Elaeophorbia drupifera (Thonn.) Stapf. (Euphorbiaceae) is used in Cameroonian folk medicine to treat
several ailments including bacterial-related diseases such as skin infections. In this study, the methanol extract from
the leaves (EDL), fractions (EDLa-d), sub-fractions EDLc1-7 and EDLc31-35 as well as isolated compounds were
tested for their antimicrobial activities against a panel of Gram-negative and Gram-positive bacteria including
multidrug resistant (MDR) phenotypes.
Methods: The broth microdilution method was used to determine the minimal inhibitory concentration (MIC) and
minimal bactericidal concentration (MBC) of the above samples; column chromatography was used for the
fractionation and purification of the leaves extract whilst the chemical structures of compounds were determined
using spectroscopic techniques.
Results: Phytochemical investigation lead to the isolation of a mixture (1:3) of stigmasterol and β-sitosterol (1 + 2),
euphol (3), sitosterol-O-β-D-xylopyranoside (4), 3,3′,4′-tri-O-methylellagic acid (5), a mixture (1:1) of afzelin and
quercetin-3-O-β-D-xylopyranoside (6 + 7), 3,3′,4′-tri-O-methylellagic acid 4-O-β-D-glucopyranoside (8), ellagic acid-4-O-
β-xylopyranoside-3,3′,4′-trimethyl ether (9) from EDLc. Crude extract and fractions displayed selective activities with
MIC values ranged from 32 to 1024 μg/mL for EDL against 84.9% of the 33 tested bacteria, 93.9% for EDLc, 69.7%
for EDLb, 33.4% for EDLa and 0.03% for EDLd. MIC values ranged from 16 to 1024 μg/mL were obtained with
EDLc3 and EDLc4 on all tested bacteria meanwhile other sub-fractions displayed selective activities. MIC value of 32
μg/mL was obtained with fractions EDLa against Escherichia coli AG100, EDLc against Enterobacer aerogenes
ATCC13048 and EA298. For sub-fractions obtained from EDLc, the lowest MIC value of 16 μg/mL was recorded with
EDLc3 against Staphylococcus aureus MRSA11. A corresponding value of 8 μg/mL against Providencia stuartii NAE16
was recorded with EDLc33 obtained from further fractionation of EDLc3. EDLc3 had MIC values below 100 μg/mL
against all tested bacteria. Compound 5 as well as the mixture (1:1) of 6 and 7 inhibited the growth of all the
tested bacteria with MICs ranged from 64 to 256 μg/mL.
Conclusion: Elaeophorbia drupifera is a potential source of phytomedicine to tackle MDR bacteria. Sub-fraction
EDLc3 was more active than all isolated compounds and deserves further investigations to develop natural drug to
combat Gram-negative, Gram-positive bacteria and otherwise MDR phenotypes.
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Background
Despite the progress in antibiotherapy, the fight against
bacterial infections still constitute a major concern
worldwide. The antibacterial fight is seriously challenged
by the development of of multi-drug resistant (MDR)
phenotypes [1]. Scientists should take into account the
resistance issue when investigating natural products for
their antimicrobial potential. In regards of the biodiver-
sity of plant kingdom, evidenced-based botanicals appear
to be undeniable source of medicine to fight bacterial re-
sistance [2, 3]. Recently, several bioactive plants against
MDR bacteria were reported. Some of these include Ery-
thrina sigmoidea [4], Cinnamomum zeylanicum, Afra-
momum citratum, Paullinia pinnata [5, 6], Allanblackia
gabonensis, Combretum molle [7] and Harungana mada-
gascariensis [8]. In our continous search of antibacterials
from plants used traditionnally to manage microbial in-
fections, we targeted Elaeophorbia drupifera (Thonn.)
Stapf. (Euphorbiaceae). The plant is used in traditional
medicine to treat skin infections, Guinea worm [9] as
well as hypertension and diabetes [10]. Leaves extract
was reported to moderately inhibit HIV-1 and HIV-2
proviral DNA copying [11], and to have relaxant effect
on vascular smooth muscle on rats [12]. The leaves
methanol extract of this plant also showed good cyto-
toxic activity towards leukemia CCRF-CEM and MDA-
MB231 breast cancer cell lines [13]. Previous phyto-
chemical investigations of the plant led to the isolation
of triterpenoids and steroids [14, 15]. In the present
study, the bioguided fractionation was undertaken for
depth investigation of the antibacterial activity of metha-
nolic extract of Elaeophorbia drupifera leaves’.
Methods
General procedure
Mass spectral data [Electrospray ionization mass spec-
trometry (ESI-MS)] were measured on a Waters Synapt
HDMS spectrometer. NMR Spectra were recorded with
an Agillent spectrometer at 400 MHz. Chemical shifts
(δ) were quoted in parts per million (ppm) from the in-
ternal standard tetramethylsilane (TMS). Deuterated di-
methyl sulfoxide (DMSO-d6), was used as solvent for the
NMR experiments. Column chromatography was per-
formed on silica gel Merck 60 F254 [(0.2–0.5 mm) and
(0.2–0.063 mm)] 70–230 and 230–400 mesh (Darmstadt,
Germany). Pre-coated silica gel 60 F254 thin layer chro-
matography (TLC) plates (Merck, Germany) were used
for monitoring fractions and spots were detected with
UV light (254 and 365 nm) and then sprayed with 50%
sulphuric acid (H2SO4) followed by heating to 100 °C.
Plant material and extraction
The leaves of Elaeophorbia drupifera were collected in
Dschang, West Region of Cameroon (5°27′N 10°04′E) in
January 2014. The plant was identified at the National
Herbarium (Yaoundé, Cameroon) where a voucher spe-
cimen was deposited under the reference number
57644/HNC [roots, leaves, bark]. The powder leaves of
E. drupifera (1300 g) was soaked in methanol (MeoH; 5 L)
for 48 h. After filtration and removal of the solvent using
a rotary evaporator under reduced pressure, 233 g of
crude extract (EDL) was obtained.
Isolation and purification of bioactive compounds from
the leaves extract of E. drupifera
Part of crude extract (213 g) was dissolved in methanol-
water (9:1 v/v), followed by a liquid-liquid fractionation
using n-hexane (Hex), dichloromethane (CH2Cl2), and
ethyl acetate (EtOAc) respectively. This afforded four
fractions: 65 g EDLa (Hex), 48 g EDLb (CH2Cl2), 91 g
EDLc (EtOAc), and 12 g residual fraction (EDLd). Of these
fractions, EDLc shows the best antibacterial activity and
was therefore subjected to further purification processes.
Fraction EDLc (85 g) was subjected to column chro-
matography (CC) over silica gel and eluted with increas-
ing gradient of n-Hex-EtoAc and EtOAc – MeoH
solvent mixtures. 167 Fractions of 300 mL each were
collected; based on TLC results, they were combined
into seven new sub- fractions tagged EDLc1 (7.5 g);
EDLc2 (3.4 g); EDLc3 (8.5 g); EDLc4 (18.6 g); EDLc5
(17.3 g); EDLc6 (16.1 g) and EDLc7 (12.9 g). EDLc1 and
EDLc7 displayed poor antibacterial effects and were not
further investigated. EDLc2 (3.2 g) was subjected to CC
over silica gel eluting with mixture of n-Hex-CH2Cl2
mixtures of increasing polarity. 69 new sub-frs of 100
mL each were collected and combined into 4 other new
sub-fractions; they were labelled EDLc21 (0.3 g); EDLc22
(1.2 g); EDLc23 (0.25 g) and EDLc24 (0.5 g). Sub-frac-
tions 18–30 (EDLc22) was further purified by silica gel
column chromatography eluting with n-hexane-Acetone
(95:5) isocratic, to afford an amorphous solid identified
and mixture (1:3) of stigmasterol and β-Sitosterol (1 + 2;
18 mg) and another white powder identified as euphol
(3; 22 mg).
EDLc3 (7.5 g) was subjected to silica gel CC eluting
with mixture solvents of n-Hex-EtOAc of increasing po-
larity. 141 sub- fractions of 100 mL of each were col-
lected and pooled into 5 sub-fractions: EDLc31 (0.6 g);
EDLc32 (1.3 g); EDLc33 (1.9 g); EDLc34 (1.4 g); EDLc35
(0.9 g). The sub-fraction EDLc33 was subjected to further
sephadex LH20 purification with n-Hex-CH2Cl2-MeOH
(9:2:0.5) mixture. Two new sub-fractions named EDL331
(0.4 g) and EDL332 (0.9 g) were obtained. EDL332 was
further subjected to another silica gel CC eluting with di-
chloromethane- acetone (98:2) isocratic system to afford a
white powder identified sitosterol 3-O-β-D-xylopyranoside
(4; 405.2 mg) and a brownish powder identified 3,3′,4′-
tri-O-methylellagic acid (5; 8 mg).
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EDLc4 (18.5 g) was subjected to CC over silica gel
eluting with n-Hex-acetone mixtures and MeOH of in-
creasing polarity. 108 sub-fractions of 100 mL each were
collected and regrouped based on their TLC profile into
4 sub-fractions named EDLc41 (3.8 g), EDLc42 (4.1 g),
EDLc43 (3.6 g) and EDLc44 (2.8 g). Compound 5 (17 mg)
was obtained in sub-fractions (EDLc41 – 44).
Sub-fraction EDLc5 (17.2 g) was subjected to silica gel
CC eluting with a gradient of CH2Cl2-EtOAc and
EtOAc-MeOH of increasing polarity, and was collected
in 143 new sub-fractions of 100 mL each were collected.
They were further pooled upon TLC analysis into five
sub-fraction named EDLc51 (3.6 g), EDLc52 (2.2 g),
EDLc53 (2.4 g), EDLc54 (1.9 g) and EDLc55 (3 g).
EDLc53 and EDLc54 were further subjected to Sephadex
LH20 CC eluting with n-Hex- CH2Cl2-MeOH (7:4:0.5)
mixture to afford a yellowish gum identified a mixture
(1:1) of 3-O-rhamnopyranosyl kaemferol and 3-O-
xylopyranosyl quercetin (6 + 7; 18 mg).
Sub-fraction EDLc6 (16 g) was subjected to silica
gel CC eluting with mixture of CH2Cl2-acetone and
acetone-MeOH of increasing polarity. 119 new sub-
fractions of 100 mL of were collected and combined
based on their TLC profiles into 4 sub-fractions:
EDLc61 (3.3 g), EDLc62 (2.4 g), EDLc63 (1.2 g) and
EDLc64 (4.6 g). EDLc62 afforded a white powder
identified as 3,3′,4′-tri-O-méthylelleargic acid 4-O-β-D-




Chemicals for antimicrobial assay
The reference antibiotic (RA) used against bacteria
was chloramphenicol ≥ 98% (Sigma-Aldrich, St. Quentin
Fallavier, France) meanwhile the bacterial growth indicator
was p-iodonitrotetrazolium chloride ≥ 97% (INT, Sigma-
Aldrich).
Microbial strains and culture media
A panel of 33 bacteria belonging to Gram-negative
and Gram-positive bacteria were investigated in this
work. They included sensitive and resistant strains of
Escherichia coli, Enterobacter aerogenes, Enterobacter
cloacae, Klebsiella pneumoniae, Pseudomonas aerugi-
nosa and Providencia stuartii (Gram-negative bac-
teria) as well as Staplylococcus aureus (Gram-positive
bacteria). They were obtained clinically and from the
American Type Culture Collection (ATCC). Their
bacterial features were previously reported (Additional
file 1: Table S1) [6]. Mueller Hinton Agar (Sigma) was
used to activate the microorganisms whilst Mueller
Hinton broth (MHB; Sigma) was used for antibacterial
assays [16].
INT colorimetric assay for MIC and MBC determinations
The determinations MIC and MBC on the tested bac-
teria were monitored by the rapid INT colorimetric
assay according to described methods [17] with some
modifications [18, 19]. The test samples and RA were
dissolved in dimethylsulfoxide (DMSO)/MHB. The final
concentration of DMSO was lower than 2.5% and does
not affect the microbial growth. The solution obtained
was then added to MHB, and serially diluted two fold
(in a 96- wells microplate). The bacterial concentration
was 1.5 × 106 CFU/mL. The plates were incubated at
37 °C for 18 h. The assay was repeated thrice. Wells
containing MHB, 100 μL of inoculum and DMSO to
a final concentration of 2.5% served as negative con-
trol. The MIC of samples was detected after 18 h in-
cubation at 37 °C, following addition (40 μL) of 0.2
mg/mL of INT and incubation at 37 °C for 30 min as
the lowest sample concentration that prevented the
color change of the medium and exhibited complete
inhibition of microbial growth [17]. The MBC was
determined by adding 50 μL aliquots of the prepara-
tions, which did not show any growth after incuba-
tion during MIC assays, to 150 μL of MHB. These
preparations were incubated at 37 °C for 48 h. The
MBC was regarded as the lowest concentration of
samples, which did not produce a color change after
addition of INT as mentioned above [20, 21].
Results
Structural determination
The chemical structures of compounds from the leaves
of E. drupifera were elucidated using physical and NMR
data and comparison with literature. The isolated
compounds were identified as the mixture (1:3) of
stigmasterol and β-sitosterol (1 + 2) [22]; euphol
C30H50O (3; m.p. 113.8–114.5
oC; m/z 426; [α]D +31
(c 0.2, CH2Cl2)) [23], sitosterol-O-β-D-xylopyranoside
C34H58O5 (4; m.p. 271–273
oC; m/z 546; [α]D – 50.1
(c 0.9, DMSO-d6)) [24], 3,3′,4′-tri-O-methylellagic acid
C17H12O8 (5; m.p. 287–288.5
oC; m/z 344) [25], the mix-
ture (1:1) of afzelin and quercetin-3-O-β-D-xylopyranoside
(6 + 7) [26, 27]; 3,3′,4′-tri-O-methylellagic acid 4-O-β-D-
glucopyranoside C23H22O13 (8; m.p. 260-262 °C; m/z
506) [28] and ellagic acid-4-O-β-xylopyranoside-3,3′,4′-
trimethyl ether C22H20O12 (9; m.p. 196.5–198.1 °C; m/z
476) [29] (Fig. 1). Extracts, fractions, compounds and the
mixtures of two compounds identified in the leaves of
E. drupifera were tested for their antimicrobial activities
on a panel of Gram-negative and Gram-positive bacteria.
The results are reported in Tables 1, 2, 3 and 4.
Antibacterial activity
Crude leaves extract (EDL), fractions EDLa-d and chlor-
amphenicol were tested on a panel of 33 bacteria. The
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results summarized in Table 1 reveal selective activities
with MIC values ranged from 32 to 1024 μg/mL for EDL
against 28/33 (84.9%) tested bacteria as well as EDLc,
EDLb, EDLa and EDLd respectively against 31/33
(93.9%), 23/33 (69.7%), 12/33 (33.4%) and 1/33 (0.03%)
tested bacteria. MIC values below 1024 μg/mL were also
recorded with chloramphenicol on 32/33 (97.0%) tested
bacteria. MBC values below1024 μg/mL were obtained
with EDLa-d as well as their mother extract EDL and
RA on some of the tested bacterial strains. However, the
recorded values were generally high. Table 2 reports the
MIC and MBC values of sub-fractions from EDLc
(EDLc1–7) against a panel of 26 bacteria. It appears that
MIC values ranged from 16 to 1024 μg/mL were ob-
tained with EDLc3 and EDLc4 on all tested bacteria
meanwhile other sub-fractions displayed selective activ-
ities. Their inhibitory effects were noted on 24/26
(92.3%), 22/26 (84.6%), 13/26 (50.0%), 10/26 (38.5%) and
8/26 (30.8%) tested bacteria. Further investigations of
EDLc3 yielded five new sub-fractions (EDL31 to EDL35)
with selective activities (Table 3). MIC values ranged
from 8 to 1024 μg/mL on 23/24 (95.8%) tested bacteria
Fig. 1 Chemical structures of compounds isolated from the leaves of Elaoephorbia drupifera. Mixture of stigmasterol and β-sitosterol (1 + 2);
euphol (3); sitosterol-O-β-D-xylopyranoside (4); 3,3′,4′-tri-O-methylellagic acid (5); mixture of afzelin and quercetin-3-O-β-D-xylopyranoside (6 + 7);
3,3′,4′-tri-O-methylellagic acid 4-O-β-D-glucopyranoside (8); ellagic acid-4-O-β-xylopyranoside-3,3′,4′-trimethyl ether (9)
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Table 1 MIC and MBC (in μg/mL) of crude extract, fractions of E. drupifera leaves and chloramphenicol against the panel of 33 bacteria
Bacterial strains Tested samples and MICs MIC and MBC in parenthesis (in μg/mL)
Crude extract Fractions Reference drug
EDL EDLa EDLb EDLc EDLd CHL
Escherichia coli
ATCC8739 - 64 (1024) 128 (1024) 64 (1024) - 2 (128)
ATCC10536 256 (-) - - 128 (1024) - <2 (64)
AG100 1024 (-) 32 (512) - 128 (512) - 8 (128)
AG100A 512 (-) 1024 (-) 1024 (-) 256 (1024) 512 (-) ˂2 (128)
AG100ATET 1024 (-) 1024 (-) 1024 (-) - - 32 (-)
AG102 512 (-) 256 (-) 256 (1024) 256 (-) - 64 (-)
MC4100 256 (-) - - 512 (-) - 16 (-)
W3110 512 (-) 256 (1024) 128 (1024) 128 (-) - 2 (-)
Pseudomonas aeruginosa
PA01 - 1024 (-) 1024 (-) 256 (-) - 32 (-)
PA124 - 1024 (-) - 128 (-) - 128 (-)
Enterobacter aerogenes
ATCC13048 - - - 32 (512) - 4 (32)
EA-CM64 512 (-) - 512 (1024) 1024 (-) - 256 (-)
EA3 1024 (-) - 512 (-) 64 (512) - 256 (-)
EA27 512 (-) - - 512 (-) - 32 (-)
EA289 512 (-) 1024 (-) 512 (-) 128 (1024) - 64 (-)
EA298 512 (-) - 256 (1024) 32 (128) - 128
Providencia stuartii
NEA16 512 (-) - 256 (512) 256 (-) - 32 (256)
ATCC29916 1024 (-) - 256 (1024) 256 (512) - 16 (256)
PS2636 512 (-) 512 (-) 256 (-) 64 (512) - 16 (256)
PS299645 1024 (-) - - 64 (128) - 64 (-)
Klebsiella pneumoniae
ATCC11296 512 (-) - 1024 (-) 128 (512) - 8 (256)
KP55 512 (-) 1024 (-) 256 (1024) 128 (512) - 32 (256)
KP63 512 (-) 1024 (-) 1024 (-) 128 (512) - 32 (-)
K24 512 (-) - - - - 64 (256)
K2 1024 (-) - 512 (1024) 64 (512) - 8 (256)
Enterobacter cloacae
BM47 - - 256 (-) 1024 (-) - 256 (-)
BM67 512 (-) - 512 (-) 256 (1024) - -
BM94 512 (-) - 1024 (-) 1024 (-) - 128 (-)
Staphylococcus aureus
ATCC 25923 128 (1024) - 1024 (-) 512 (-) - 8 (128)
MRSA 3 1024 (-) - - 1024 (-) - 16 (-)
MRSA 4 512 (-) - - 1024 (-) - 64 (-)
MRSA 11 512 (-) - 1024 (-) 512 (-) - 32 (-)
MRSA 12 512 (-) - 256 (1024) 128 (1024) - 16 (256)
Tested samples were crude methanol extract of E. drupifera (EDL), hexane fraction (EDLa), dichloromethane fraction (EDLb), ethyl acetate fraction (EDLc), residual
fraction (EDLc), and chloramphenicol (CHL); -: MIC or MBC values above 1024 μg/mL
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for EDLc32, EDLc34 and EDLc35. It should be noted
that MBC values noted with EDL31-EDL35 were gener-
ally above 1024 μg/mL. A keen look of data from
Tables 1 and 3 indicated that the ratio MBC/MIC were
generally above 4. The antibacterial activities of the iso-
lated compounds and the mixtures of two compounds
are compiled in Table 4. Compound 5 as well as the
mixture (1:1) of 6 and 7 inhibited the growth of all the
14 tested bacteria with MIC values ranged from 64 to
256 μg/mL. Compounds 3 and 8 inhibited respectively
the growth of 1/14 (7.1%) and 13/14 (92.9%) tested bac-
teria meanwhile 4, 9 as well as the mixture (1:3) of 1
and 2 were not active at up to 256 μg/mL.
Discussion
In the present study, we identified 9 compounds
amongst which were 4 terpenoids (1–4), 2 flavonoid gly-
cosides (6 and 7), 3 ellagic acid derivatives (5, 8 and 9).
Table 2 MIC and MBC (in μg/mL) of sub-fractions of ethyl acetate fraction EDLc against the panel of 26 bacteria
Bacterial strains Sub-fractions, MIC and MBC in parenthesis (in μg/mL)
EDLc1 EDLc2 EDLc3 EDLc4 EDLc5 EDLc6 EDLc7
Escherichia coli
ATCC8739 1024 (-) 512 (-) 64 (-) 512 (-) 512 (-) - -
ATCC 10536 - 1024 (-) 32 (-) 64 (-) 512 (-) 1024 (-) 1024 (-)
AG100A - 512 (-) 64 (256) 256 (-) - - -
AG102 - 128 (-) 32 (256) 256 (-) 64 (512) 1024 (-) -
W3110 - - 16 (-) 64 (-) 512 (-) 1024 -
Pseudomonas aeruginosa
PA 01 - 128 (-) 64 (-) 512 (-) 1024 (-) 1024 (-) 1024 (-)
PA 124 - 1024 (-) 64 (-) 256 (-) 512 (-) 1024 (-) 1024 (-)
Enterobacter aerogenes
ATCC13048 512 (-) 256 (-) 128 (256) 512 (-) 1024 (-) - 1024 (-)
EA-CM64 - 1024 (-) 64 (256) 512 (-) - - -
EA289 - 128 (-) 32 (-) 64 (-) 512 (-) 1024 (-) 512 (-)
EA27 1024 (-) 1024 (-) 128 (-) 256 (-) 512 (-) - 1024 (-)
Providencia stuartii
NEA16 1024 (-) 512 (-) 64 (-) 256 (-) - - -
ATCC29916 - 256 (-) 64 (-) 256 (-) 512 (-) - -
PS2636 512 (-) 128 (-) 16 (-) 64 (-) 256 (-) 1024 (-) 512 (-)
PS299645 128 (-) 128 (-) 16 (-) 256 (-) 512 (-) 1024 (-) 512 (-)
Klebsiella pneumoniae
ATCC11296 1024 (-) 512 (-) 64 (-) 256 (-) 512 (-) - -
KP55 - 128 (-) 32 (-) 512 (-) 1024 (-) 512 (-) 1024 (-)
KP63 - 1024 (-) 64 (-) 512 (-) 512 (-) - 1024 (-)
K2 256 (-) 64 (-) 16 (-) 64 (-) - - 512 (-)
Enterobacter cloacae
BM47 - 256 (1024) 64 (256) 256 (-) 512(-) - -
BM67 - 512(-) 64 (256) 256 (-) 1024 (-) - -
BM94 - 1024(-) 32 (256) 64 (-) 1024 (-) - 1024 (-)
Staphylococcus aureus
ATCC25923 - - 64 (512) 512 (-) 1024 (-) - -
MRSA 3 - 1024 (-) 64 (256) 256 (-) 512 (-) - -
MRSA 4 - 256 (-) 32 (256) 256 (-) 512 (-) - -
MRSA 11 - 1024 (-) 16 (-) 128 (-) 256 (-) 1024 (-) 1024 (-)
-: MIC or MBC values above 1024 μg/mL
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Among terpenoids were steroids (1 and 2), a steroid glu-
coside (4) and a triterpenoid (3). The isolation of com-
pounds such as euphol (3), tirucallol, euphorbol, ingenol
elaeophorbate, epitaraxerol, taraxerone, friedelin, lup-
20(29)-en-3-one or lupenone, lupeol, olean-12-ene-3-
one, olean-12-ene-3-ol, elaeophorbate in E. drupifera
was previously reported [14, 15]. However, in the present
work, fewer compounds as well as other not previously
isolated ones were isolated, probably due to the fact that
the purification was guided by the antibacterial activity
and hence all fractions and sub-fractions were not
explored. According to established criteria, the antibac-
terial activity of a plant extract is considered to be
significant when MIC is below 100 μg/mL, moderate
when 100 μg/mL <MIC < 625 μg/mL or low when
MIC > 100 μg/mL [30, 31]. Therefore, the antibacterial
activity of the leaves extract (EDL) of E. drupifera
could be considered as moderate, as MIC values
below 625 μg/mL were obtained on the majority of
the tested bacteria (Table 1). However, fractionation
of EDL afforded more active samples, and the anti-
bacterial effects of EDLc, EDLc3, EDLc4, EDLc32 to
EDLc35 could be considered important. In fact, the
lowest MIC value of 32 μg/mL was obtained with
fractions EDLa against Escherichia coli AG100, EDLc
against Enterobacer aerogenes ATCC13048and EA298.
For sub-fractions obtained from EDLc, the lowest
MIC value of 16 μg/mL was noted with EDLc3 against
Staphylococcus aureus MRSA11. A corresponding value of
8 μg/mL against Providencia stuartii NAE16 was recorded
with EDLc33 obtained from further fractionation of
Table 3 MIC and MBC (in μg/mL) activities of sub-fractions
EDLc3 against the panel of 24 bacteria
Bacterial strains Sub-fractions, MIC and MBC in parenthesis (in μg/mL)
EDLc31 EDLc32 EDLc33 EDLc34 EDLc35
Escherichia coli
ATCC8739 - (-) 256 (-) 64 (-) 256 (-) 512 (-)
ATCC 10536 256 (-) 64 (-) 64 (-) 32 (-) 128 (-)
AG100A 128 (-) 64 (-) 32 (-) 128 (512) 256 (-)
AG102 128 (-) 128 (-) 32 (1024) 256 (1024) 1024 (1024)
Pseudomonas aeruginosa
PA 01 256 (-) 32 (-) 256 (1024) 32 (1024) 64 (-)
PA 124 - - - - -
Enterobacter aerogenes
ATCC13048 - 256 (512) 512 (-) 128 (-) 256 (512)
EA-CM64 - 512 (-) 256 (-) 256 (1024) 256 (-)
EA289 128 (-) 32 (-) 64 (-) 32 (-) 64 (-)
EA27 - 128 (-) 256 (-) 512 (-) 256 (-)
Providencia stuartii
NEA16 - 32 (-) 8 (-) 32 (-) 128 (1024)
ATCC29916 512 (-) 64 (-) 512 (-) 64 (-) 128 (-)
PS2636 128 (-) 32 (-) 128 (-) 16 (-) 64 (-)
PS299645 - 128 (-) 512 (-) 1024 (-) 1024 (-)
Klebsiella pneumoniae
ATCC11296 512 (-) 256 (-) - 64 (-) 128 (-)
KP63 - 32 (512) 64 (1024) 128 (1024) 256 (-)
K2 16 (-) 128 (-) 64 (-) 16 (-) 32 (-)
Enterobacter cloacae
BM47 - 256 (-) 1024 (-) 128 (-) 256 (-)
BM67 - 256 (512) 64 (-) 64 (-) 128 (1024)
BM94 - 64 (-) 256 (-) 1024 (-) 1024 (-)
Staphylococcus aureus
ATCC25923 - 256 (-) 256 (-) 128 (-) 256 (-)
MRSA 3 - 256 (-) 64 64 (1024) 128 (1024)
MRSA 4 - 256 (-) 256 64 (-) 128 (-)
MRSA 11 256 (-) 64 (-) 128 16 (1024) 64 (1024)
-: MIC or MBC values above 1024 μg/mL
Table 4 MIC (in μg/ml) of compounds isolated from of
E. drupifera leaves against the panel of 14 bacteria
Bacterial strains Compounds and MIC (in μg/ml)
3 5 6 + 7 8
Escherichia coli
ATCC8739 - 128 64 256
ATCC10536 - 128 128 256
AG102 - 128 64 64
Pseudomonas aeruginosa
PA 01 - 128 128 -
PA 124 256 128 128 64
Enterobacter aerogenes
ATCC13048 - 128 64 128
EA-CM64 - 128 128 128
Providencia stuartii
ATCC29916 - 128 128 256
PS2636 - 64 64 256
Klebsiella pneumoniae
ATCC11296 - 128 128 256
KP55 - 128 128 128
Staphylococcus aureus
ATCC 25923 - 128 64 64
MRSA3 - 256 128 64
MRSA4 - 256 128 256
Tested compounds were a mixture (1:3) of stigmasterol and β-sitosterol (1 + 2);
euphol (3); sitosterol-O-β-D-xylopyranoside (4); 3,3′,4′-tri-O-methylellagic acid (5);
mixture 1:1 of afzelin and quercetin-3-O-β-D-xylopyranoside (6 + 7); 3,3′,4′-tri-O-
methylellagic acid 4-O-β-D-glucopyranoside (8); ellagic acid-4-O-β-xylopyranoside-
3,3′,4′-trimethyl ether (9). No MBC was detected at 256 μg/mL for all compounds;
MIC values were >256 μg/mL for 1 + 2, 4 and 9
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EDLc3. These data highlight the increase of activity with
consecutive fractionation of extracts and also demonstrate
the good antibacterial potential of E. drupifera. Impor-
antly, the MIC values obtained with the best sub-fractions
EDLc3 against Pseudomonas aeruginosa PA124, E. aero-
genes EA289, Providencia stuartii PS29964, Enterobacter
cloacae BM47, BM67, BM94, S. aureus MRSA4 (Table 2)
and EDLc33 against P. stuartii NAE16 (Table 2) were
lower than those of chormaphenicol. It should also be
highlighted that EDLc3 had MIC values below 100 μg/mL
against all the 26 tested bacteria (Table 2). The ratio
MBC/MIC obtained were generally above 4, indicating
that the studied extracts as well as the active fractions
mostly exerted bacteriostatic effects [32–34]. Also,
MIC and MBC values of the reference drug chloram-
phenicol were also very high (>64 μg/mL) on several
pathogens, confirming that most of the bacterial
strains used were MDR phenotypes. The activity of
compounds is significant when MIC < 10 μg/mL,
moderate when 10 <MIC < 100 μg/mL and low when
MIC > 100 μg/mL [30, 31]. On this basis, none of the
compound or mixtures displayed significant antibac-
terial activity. Also the lowest MIC value of 64 μg/mL
obtained with compound 5 was much more higher
than the corresponding values for the most active
fraction EDLc3 where it were isolated. This suggests
that constituents of this fraction may exert synergistic
effects. This also indicates that combating the tested
bacteria with fractions and mostly EDLc3 could be
more efficient than with isolated compounds. When
regarding the structure-activity relationship, it appears
that terpenoids were poorly or not active against the
tested bacteria. This result is not suprising, as terpe-
noids are known to generally have poor antibacterial
activity [30]. Amongst the three ellagic acid derivatives,
compound 5 and the glucoside 8 had antibacterial activ-
ities contrary to 9. Hence, it may be deduced that the sub-
stitution of a glucosyl- (8) group by the xylopyranosyl-
group (9) cancels the antibacterial effect of the ellagic acid
derivative 9.
To the best of our knowledge, the identification of the
antibacterial constituents of E. drupifera is being re-
ported for the first time. However, the antibacterial ac-
tivity of the leave of extract of the plant was reported on
Staphylococcus aureus and Streptococcus pyogenes [9].
The present study therefore provides more information
on the antibacterial potential of E. drupifera and identi-
fied the bioactive components of plant. Also, compound
5 was previously reported against a panel of sensitive
Gram-positive and Gram-negative bacteria, with MIC
values ranged from 9.76 to 156.25 μg/mL [18]. Data
obtained in the present study (MIC ranged from 64 to
256 μg/mL) are in consistence with previous and also
confirm the activity of compound 5 against MDR bacteria.
Conclusions
The results of the present investigation are very inter-
esting, taking in account the medical importance of
the studied microorganisms. The most active fraction
of the plant, identified as EDLc3 displayed significant
antibacterial activity on a panel of 26 tested bacteria
including both sensitive and MDR Gram-negative and
Gram-positive bacteria. This fraction could therefore
be useful in the management of bacterial infection in-
cluding MDR phenotypes. The bioactive constituents
of the plant include 3,3′,4′-tri-O-methylelleargic acid,
3-O-rhamnopyranosyl kaempherol, 3-O-rhamnopyra-
nosyl quercetin and 3,3′,4′-tri-O-méthylelleargic acid
4-O-β-D-glucopyranoside.
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